1. Home
  2. STRA vs ANIP Comparison

STRA vs ANIP Comparison

Compare STRA & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

STRA

Strategic Education Inc.

HOLD

Current Price

$80.32

Market Cap

1.8B

Sector

Real Estate

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$74.11

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRA
ANIP
Founded
2017
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.7B
IPO Year
1996
1999

Fundamental Metrics

Financial Performance
Metric
STRA
ANIP
Price
$80.32
$74.11
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$96.50
$107.33
AVG Volume (30 Days)
302.2K
338.3K
Earning Date
04-23-2026
05-08-2026
Dividend Yield
2.98%
N/A
EPS Growth
15.85
419.23
EPS
5.41
3.32
Revenue
$997,137,000.00
$206,547,000.00
Revenue This Year
$4.71
$19.88
Revenue Next Year
$2.48
$15.77
P/E Ratio
$14.85
$22.32
Revenue Growth
57.23
2.47
52 Week Low
$72.17
$56.71
52 Week High
$92.98
$99.50

Technical Indicators

Market Signals
Indicator
STRA
ANIP
Relative Strength Index (RSI) 50.00 44.96
Support Level $79.98 $62.89
Resistance Level $84.71 $85.12
Average True Range (ATR) 3.18 2.87
MACD -0.01 -0.00
Stochastic Oscillator 35.02 50.45

Price Performance

Historical Comparison
STRA
ANIP

About STRA Strategic Education Inc.

Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: